Bliss GVS Pharma Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bliss GVS Pharma Limited with three other
companies in this sector in India:
Marksans Pharma Limited
sales of 7.67 billion Indian Rupees [US$119.37 million]
Orchid Pharma Ltd
(8.07 billion Indian Rupees [US$125.64 million]
Eris Lifesciences Ltd
(7.25 billion Indian Rupees [US$112.80 million]
of which 100%
During the year ended March of 2017, sales at
Bliss GVS Pharma Limited were 8.00 billion Indian Rupees (US$124.44 million).
increase of 46.2%
versus 2016, when the company's sales were 5.47 billion Indian Rupees.
This was the third consecutive year of growth at Bliss GVS Pharma Limited.